CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −485 | $526.04 | $255K | 333,338 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,610 | $526.84 | $1.4M | 330,728 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,211 | $527.82 | $639K | 329,517 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −874 | $528.91 | $462K | 328,643 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −760 | $529.80 | $403K | 327,883 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −400 | $531.22 | $212K | 327,483 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −489 | $533.24 | $261K | 326,994 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −324 | $534.19 | $173K | 326,670 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −107 | $535.40 | $57K | 326,563 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −790 | $536.49 | $424K | 325,773 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −570 | $537.60 | $306K | 325,203 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −680 | $538.46 | $366K | 324,523 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $539.47 | $43K | 324,443 |
| 2026-07-22 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 293,910 | ||
| 2026-07-21 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $135.42 | $1.3M | 333,943 |
| 2026-07-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $524.37 | $63K | 333,823 |
| 2026-07-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $526.24 | $84K | 333,663 |
| 2026-07-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $527.46 | $127K | 333,423 |
| 2026-07-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −509 | $529.55 | $270K | 332,914 |
| 2026-07-21 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,926 | $530.50 | $1.0M | 330,988 |
Page 63 of 64 · 1,267 trades